LIMN

Liminatus Pharma, Inc. Class A Common StockNASDAQHealthcare

$0.19+6.63%ClosedMarket Cap: $5.0M

As of 2026-04-07

Valuation

P/E (TTM)

—

PEG

—

P/B

-0.45

P/S

0.00

EV/EBITDA

-2.06

DCF Value

$-0.05

FCF Yield

-199.2%

Div Yield

0.0%

Margins & Returns

Gross Margin

0.0%

Operating Margin

0.0%

Net Margin

0.0%

ROE

201.4%

ROA

-1990.4%

ROIC

35.6%

Income Statement

Period	Revenue	Gross Margin	Operating Income	Net Income	EPS	Dividend
Q4 2025	$0.00	NaN%	$-1.1M	$-8.5M	$2.18	—
FY 2025	$0.00	NaN%	$-3.0M	$-10.2M	$-0.43	—
Q3 2025	$0.00	NaN%	$-701.2K	$-1.8M	$-0.07	—
Q2 2025	$0.00	NaN%	$-1.1M	$113.3K	$0.00	—
Q1 2025	$0.00	NaN%	$-255.00	$-255.00	$-2.55	—
Q4 2024	$0.00	NaN%	$-522.8K	$-868.3K	$-0.12	—
FY 2024	$0.00	NaN%	$-2.9M	$-2.9M	$-0.40	—
Q3 2024	$0.00	NaN%	$-1.0M	$-642.9K	$-0.09	—
Q2 2024	$0.00	NaN%	$-642.1K	$-534.9K	$-0.07	—
Q1 2024	$0.00	NaN%	$-1.7M	$-1.8M	$-0.23	—
Q4 2023	$0.00	NaN%	$-642.7K	$-486.6K	$-0.07	—
FY 2023	$0.00	NaN%	$-2.6M	$-1.2M	$-0.15	—